BACKGROUND: Patient adherence to recommended use of ICS is questionable in asthma, with irregular use or interruptions occurring frequently. Factors explaining discontinuation of controller therapy could orientate interventions. The characteristics of patients with interruptions of inhaled corticosteroids (ICSs), intentional or accidental, were investigated. METHODS: Asthma patients regularly prescribed ICS by GPs (Cegedim network) were included. Patients' characteristics and behaviours toward ICS (accidental/intentional interruptions, less frequent use of ICS and change in dosing) were identified from self-report questionnaires, and linked to data prescription database. Interrelations between declared behaviours toward ICS were studied with a Multiple Component Analysis (MCA) and the correlates of ICS interruptions were identified. RESULTS: During the past 3 months, 31.6% of 204 patients (mean age: 53.8 years, females: 59.3%) intentionally interrupted ICS when feeling better, 25.4% forgot ICS and 18.3% deliberately changed the doses. A quarter of patients considered constant use of respiratory medicines as unhealthy. MCA revealed that intentional, accidental interruptions and less frequent use of ICS were closely correlated. Risk of intentional interruption was increased when patients considered constant use of respiratory therapy to be unhealthy (OR=3.36, 95%CI=[1.47-7.66]). Conversely, risk was significantly lower when ICS was associated or combined with another controller (OR=0.24, 95%CI=[0.08-0.73]), compared to ICS in monotherapy. Less frequent interruptions were observed in patients older than 65 (OR=0.35, 95%CI=[0.13-0.89]). CONCLUSIONS: Our study suggests that discontinuation of use of controllers is associated with other inadequate behaviours or beliefs about inhaled controllers. Efforts should be targeted at patients' perceptions and behaviours toward controller therapy.
BACKGROUND:Patient adherence to recommended use of ICS is questionable in asthma, with irregular use or interruptions occurring frequently. Factors explaining discontinuation of controller therapy could orientate interventions. The characteristics of patients with interruptions of inhaled corticosteroids (ICSs), intentional or accidental, were investigated. METHODS:Asthmapatients regularly prescribed ICS by GPs (Cegedim network) were included. Patients' characteristics and behaviours toward ICS (accidental/intentional interruptions, less frequent use of ICS and change in dosing) were identified from self-report questionnaires, and linked to data prescription database. Interrelations between declared behaviours toward ICS were studied with a Multiple Component Analysis (MCA) and the correlates of ICS interruptions were identified. RESULTS: During the past 3 months, 31.6% of 204 patients (mean age: 53.8 years, females: 59.3%) intentionally interrupted ICS when feeling better, 25.4% forgot ICS and 18.3% deliberately changed the doses. A quarter of patients considered constant use of respiratory medicines as unhealthy. MCA revealed that intentional, accidental interruptions and less frequent use of ICS were closely correlated. Risk of intentional interruption was increased when patients considered constant use of respiratory therapy to be unhealthy (OR=3.36, 95%CI=[1.47-7.66]). Conversely, risk was significantly lower when ICS was associated or combined with another controller (OR=0.24, 95%CI=[0.08-0.73]), compared to ICS in monotherapy. Less frequent interruptions were observed in patients older than 65 (OR=0.35, 95%CI=[0.13-0.89]). CONCLUSIONS: Our study suggests that discontinuation of use of controllers is associated with other inadequate behaviours or beliefs about inhaled controllers. Efforts should be targeted at patients' perceptions and behaviours toward controller therapy.
Authors: Mary E Bollinger; Kim E Mudd; Adam Boldt; Van Doren Hsu; Mona G Tsoukleris; Arlene M Butz Journal: Ann Allergy Asthma Immunol Date: 2013-07-21 Impact factor: 6.347
Authors: Emilia Jumbe Marsden; Somwe Wa Somwe; Chishala Chabala; Joan B Soriano; Cesar Picado Vallès; Julio Anchochea Journal: BMC Pulm Med Date: 2016-02-12 Impact factor: 3.317
Authors: Christer Janson; Simone Accordini; Lucia Cazzoletti; Isa Cerveri; Sebastien Chanoine; Angelo Corsico; Diogenes Seraphim Ferreira; Judith Garcia-Aymerich; David Gislason; Rune Nielsen; Ane Johannessen; Rain Jogi; Andrei Malinovschi; Jesús Martinez-Moratalla Rovira; Alessandro Marcon; Isabelle Pin; Jennifer Quint; Valerie Siroux; Enrique Almar; Valeria Bellisario; Karl A Franklin; José A Gullón; Mathias Holm; Joachim Heinrich; Dennis Nowak; José Luis Sánchez-Ramos; Joost J Weyler; Deborah Jarvis Journal: ERJ Open Res Date: 2019-02-01
Authors: Mna Van Steenis; Ja Driesenaar; Jm Bensing; R Van Hulten; Pc Souverein; L Van Dijk; Pagm De Smet; Am Van Dulmen Journal: Patient Prefer Adherence Date: 2014-01-13 Impact factor: 2.711